معرفی
Dr Sarah Derby is a Clinical Lecturer at the University of Glasgow, affiliated with the Clinical Research Gartnavel department. Her research focuses on neuro-oncology, radiation therapy, and cancer treatment mechanisms, particularly in glioblastoma multiforme. She has contributed to clinical trials and translational studies on PARP inhibitors, ATR kinase inhibition, and cancer survivorship.
- Key Research Areas: Glioblastoma invasion mechanisms, radiosensitization strategies, cancer survivorship epidemiology
- Clinical Expertise: Geriatric oncology, radical radiotherapy alternatives, neuro-oncological complications
Her recent publications highlight trends in glioblastoma treatment optimization using DNA damage response inhibitors, stroke risk analysis in cancer survivors, and clinical evaluation of radiotherapy combinations. She actively contributes to multidisciplinary oncology research through systematic reviews, clinical trials, and case studies.
۰مقاله منتشرشده
